Variations in serum levels of interleukin (IL)-1β, IL-2, IL-6, and tumor necrosis factor-α during specific immunotherapy
- 31 March 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 86 (3), 311-313
- https://doi.org/10.1016/s1081-1206(10)63304-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Differential regulation of allergen-specific TH2- but not TH1-type responses by alveolar macrophages in atopic asthmaJournal of Allergy and Clinical Immunology, 1998
- Immunologic changes associated with allergen immunotherapyJournal of Allergy and Clinical Immunology, 1998
- Allergen exposure induces the activation of allergen‐specific Th2 cells in the airway mucosa of patients with allergic respiratory disordersEuropean Journal of Immunology, 1993
- The importance of Th2‐like cells in the pathogenesis of airway allergic inflammationClinical and Experimental Allergy, 1993
- Allergic and Nonallergic Asthmatics Have Distinct Patterns of T-Cell Activation and Cytokine Production in Peripheral Blood and Bronchoalveolar LavageAmerican Review of Respiratory Disease, 1992
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- Inflammatory cytokinesClinical Immunology and Immunopathology, 1992
- Cytokine production by mast cells and basophilsCurrent Opinion in Immunology, 1991
- Immunotherapy and allergic inflammationClinical and Experimental Allergy, 1991
- Basophil mast cell and eosinophil growth and differentiation factors in human allergic diseaseClinical and Experimental Allergy, 1989